Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M J Millan

Showing results (171-180 of 224) with videos related to

Pageof 23
Sort By:
Agents and Actions|December 1, 1988
Peptide neuroanatomy of adjuvant-induced arthritic inflammation in ratE Weihe, D Nohr, M J Millan, et al.
Neuroscience|April 16, 1998
Simultaneous quantification of serotonin, dopamine and noradrenaline levels in single frontal cortex dialysates of freely-moving rats reveals a complex pattern of reciprocal auto- and heteroreceptor-mediated control of releaseA Gobert, J M Rivet, V Audinot, et al.
British Journal of Pharmacology|April 15, 2014
Agomelatine: mechanism of action and pharmacological profile in relation to antidepressant propertiesB Guardiola-Lemaitre, C De Bodinat, P Delagrange, et al.
Neuroendocrinology|January 1, 1986
Stress-induced alterations in the levels of messenger RNA coding for proopiomelanocortin and prolactin in rat pituitaryV Höllt, R Przewłocki, I Haarmann, et al.
Brain Research|August 5, 1985
Spinal cord dynorphin may modulate nociception via a kappa-opioid receptor in chronic arthritic ratsM J Millan, M H Millan, C W Pilcher, et al.
Bioorganic & Medicinal Chemistry Letters|August 18, 1999
Novel benzopyrano[3,4-c]pyrrole derivatives as potent and selective dopamine D3 receptor antagonistT Dubuffet, A Newman-Tancredi, D Cussac, et al.
Life Sciences|October 18, 1982
Endogenous opioids, circadian rhythms, nutrient deprivation, eating and drinkingL D Reid, A M Konecka, R Przewłocki, et al.
Neuropharmacology|November 12, 2013
Valproate improves prepulse inhibition deficits induced by corticotropin-releasing factor independent of GABA(A) and GABA(B) receptor activationT N Douma, M J Millan, P M Verdouw, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|August 19, 2003
Comparison of hippocampal G protein activation by 5-HT(1A) receptor agonists and the atypical antipsychotics clozapine and S16924A Newman-Tancredi, J-M Rivet, D Cussac, et al.
Neuropharmacology|February 13, 2001
S 14506: novel receptor coupling at 5-HT(1A) receptorsG Milligan, E Kellett, C Dacquet, et al.
Pageof 23

Showing results (171-180 of 224) with videos related to

Sort By:
Pageof 23
Agents and Actions|December 1, 1988
Peptide neuroanatomy of adjuvant-induced arthritic inflammation in ratE Weihe, D Nohr, M J Millan, et al.
Neuroscience|April 16, 1998
Simultaneous quantification of serotonin, dopamine and noradrenaline levels in single frontal cortex dialysates of freely-moving rats reveals a complex pattern of reciprocal auto- and heteroreceptor-mediated control of releaseA Gobert, J M Rivet, V Audinot, et al.
British Journal of Pharmacology|April 15, 2014
Agomelatine: mechanism of action and pharmacological profile in relation to antidepressant propertiesB Guardiola-Lemaitre, C De Bodinat, P Delagrange, et al.
Neuroendocrinology|January 1, 1986
Stress-induced alterations in the levels of messenger RNA coding for proopiomelanocortin and prolactin in rat pituitaryV Höllt, R Przewłocki, I Haarmann, et al.
Brain Research|August 5, 1985
Spinal cord dynorphin may modulate nociception via a kappa-opioid receptor in chronic arthritic ratsM J Millan, M H Millan, C W Pilcher, et al.
Bioorganic & Medicinal Chemistry Letters|August 18, 1999
Novel benzopyrano[3,4-c]pyrrole derivatives as potent and selective dopamine D3 receptor antagonistT Dubuffet, A Newman-Tancredi, D Cussac, et al.
Life Sciences|October 18, 1982
Endogenous opioids, circadian rhythms, nutrient deprivation, eating and drinkingL D Reid, A M Konecka, R Przewłocki, et al.
Neuropharmacology|November 12, 2013
Valproate improves prepulse inhibition deficits induced by corticotropin-releasing factor independent of GABA(A) and GABA(B) receptor activationT N Douma, M J Millan, P M Verdouw, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|August 19, 2003
Comparison of hippocampal G protein activation by 5-HT(1A) receptor agonists and the atypical antipsychotics clozapine and S16924A Newman-Tancredi, J-M Rivet, D Cussac, et al.
Neuropharmacology|February 13, 2001
S 14506: novel receptor coupling at 5-HT(1A) receptorsG Milligan, E Kellett, C Dacquet, et al.
Pageof 23